_id

69105433ccc777a4e85d5564

Ticker

CRBP

Name

Corbus Pharmaceuticals Holding

Exchange

NASDAQ

Address

500 River Ridge Drive, Norwood, MA, United States, 02062

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.corbuspharma.com

Description

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.

Last Close

9.68

Volume

199008

Current Price

9.7

Change

0.20661157024792948

Last Updated

2025-11-29T11:49:26.523Z

Image

-

Ipo Date

2014-11-11T00:00:00.000Z

Market Cap

202562032

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.821

Sentiment Sources

1

Rating

4.7

Target Price

42.3333

Strong Buy

7

Buy

3

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

24417000

Operating Income

-24417000

Interest Expense

0

Pretax Income

-23342000

Net Income

-23342000

Eps

-1.8965982622668274

Dividends Per Share

-

Shares Outstanding

17553037

Income Tax Expense

-

EBITDA

-23342000

Operating Margin

-

Total Other Income Expense Net

1075000

Cash

26983000

Short Term Investments

76999000

Receivables

-

Inventories

-

Total Current Assets

107571000

Property Plant Equipment

1558000

Total Assets

109514000

Payables

2740000

Short Term Debt

1742000

Long Term Debt

-

Total Liabilities

17367000

Equity

92147000

Depreciation

50000

Change In Working Capital

6163000

Cash From Operations

-15550000

Capital Expenditures

0

Cash From Investing

19638000

Cash From Financing

2851000

Net Change In Cash

6939000

PE

-

PB

1.2955472299695052

ROE

-25.33126417571923

ROA

-21.31416987782384

FCF

-15550000

Fcf Percent

-

Piotroski FScore

1

Health Score

43

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3.5

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

24417000

Quarters > 0 > income Statement > operating Income

-24417000

Quarters > 0 > income Statement > interest Expense

0

Quarters > 0 > income Statement > pretax Income

-23342000

Quarters > 0 > income Statement > net Income

-23342000

Quarters > 0 > income Statement > eps

-1.8965982622668274

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

12307298

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-23342000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

1075000

Quarters > 0 > balance Sheet > cash

26983000

Quarters > 0 > balance Sheet > short Term Investments

76999000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

107571000

Quarters > 0 > balance Sheet > property Plant Equipment

1558000

Quarters > 0 > balance Sheet > total Assets

109514000

Quarters > 0 > balance Sheet > payables

2740000

Quarters > 0 > balance Sheet > short Term Debt

1742000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

17367000

Quarters > 0 > balance Sheet > equity

92147000

Quarters > 0 > cash Flow > net Income

-23342000

Quarters > 0 > cash Flow > depreciation

50000

Quarters > 0 > cash Flow > change In Working Capital

6163000

Quarters > 0 > cash Flow > cash From Operations

-15550000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

19638000

Quarters > 0 > cash Flow > cash From Financing

2851000

Quarters > 0 > cash Flow > net Change In Cash

6939000

Quarters > 0 > ratios > PE

-1.8965982622668274

Quarters > 0 > ratios > PB

1.2955472299695052

Quarters > 0 > ratios > ROE

-25.33126417571923

Quarters > 0 > ratios > ROA

-21.31416987782384

Quarters > 0 > ratios > FCF

-15550000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

100000

Quarters > 1 > income Statement > gross Profit

-100000

Quarters > 1 > income Statement > operating Expenses

19052000

Quarters > 1 > income Statement > operating Income

-19152000

Quarters > 1 > income Statement > interest Expense

0

Quarters > 1 > income Statement > pretax Income

-17662000

Quarters > 1 > income Statement > net Income

-17662000

Quarters > 1 > income Statement > eps

-1.4429738562091503

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

12240000

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-17562000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

1490000

Quarters > 1 > balance Sheet > cash

20044000

Quarters > 1 > balance Sheet > short Term Investments

96548000

Quarters > 1 > balance Sheet > receivables

1500000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

122825000

Quarters > 1 > balance Sheet > property Plant Equipment

1875000

Quarters > 1 > balance Sheet > total Assets

125085000

Quarters > 1 > balance Sheet > payables

3988000

Quarters > 1 > balance Sheet > short Term Debt

1695000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

14094000

Quarters > 1 > balance Sheet > equity

110991000

Quarters > 1 > cash Flow > net Income

-17662000

Quarters > 1 > cash Flow > depreciation

53000

Quarters > 1 > cash Flow > change In Working Capital

122000

Quarters > 1 > cash Flow > cash From Operations

-16599000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

17743000

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

1144000

Quarters > 1 > ratios > PE

-1.4429738562091503

Quarters > 1 > ratios > PB

1.0697083547314645

Quarters > 1 > ratios > ROE

-15.91300195511348

Quarters > 1 > ratios > ROA

-14.11999840108726

Quarters > 1 > ratios > FCF

-16599000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

43

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

15642000

Quarters > 2 > income Statement > gross Profit

-15642000

Quarters > 2 > income Statement > operating Expenses

4133000

Quarters > 2 > income Statement > operating Income

-19775000

Quarters > 2 > income Statement > interest Expense

0

Quarters > 2 > income Statement > pretax Income

-16978000

Quarters > 2 > income Statement > net Income

-16978000

Quarters > 2 > income Statement > eps

-1.391411244058351

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

12202000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-18578000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

2797000

Quarters > 2 > balance Sheet > cash

18900000

Quarters > 2 > balance Sheet > short Term Investments

113887000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

137360000

Quarters > 2 > balance Sheet > property Plant Equipment

2186000

Quarters > 2 > balance Sheet > total Assets

139931000

Quarters > 2 > balance Sheet > payables

4068000

Quarters > 2 > balance Sheet > short Term Debt

1650000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

12825000

Quarters > 2 > balance Sheet > equity

127106000

Quarters > 2 > cash Flow > net Income

-16978000

Quarters > 2 > cash Flow > depreciation

81000

Quarters > 2 > cash Flow > change In Working Capital

-1000000

Quarters > 2 > cash Flow > cash From Operations

-16421000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

18123000

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

1702000

Quarters > 2 > ratios > PE

-1.391411244058351

Quarters > 2 > ratios > PB

0.9311865686906989

Quarters > 2 > ratios > ROE

-13.35735527827168

Quarters > 2 > ratios > ROA

-12.133122753357013

Quarters > 2 > ratios > FCF

-16421000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

703376

Quarters > 3 > income Statement > cost Of Revenue

146000

Quarters > 3 > income Statement > gross Profit

-146000

Quarters > 3 > income Statement > operating Expenses

12459000

Quarters > 3 > income Statement > operating Income

-12605000

Quarters > 3 > income Statement > interest Expense

661985

Quarters > 3 > income Statement > pretax Income

-9530000

Quarters > 3 > income Statement > net Income

-9530000

Quarters > 3 > income Statement > eps

-0.7824634906476318

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

12179482

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-9384000

Quarters > 3 > income Statement > operating Margin

-1792.0713814517412

Quarters > 3 > income Statement > total Other Income Expense Net

3075000

Quarters > 3 > balance Sheet > cash

17198000

Quarters > 3 > balance Sheet > short Term Investments

131864000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

152976000

Quarters > 3 > balance Sheet > property Plant Equipment

2518000

Quarters > 3 > balance Sheet > total Assets

155879000

Quarters > 3 > balance Sheet > payables

4786000

Quarters > 3 > balance Sheet > short Term Debt

1606000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

13451000

Quarters > 3 > balance Sheet > equity

142428000

Quarters > 3 > cash Flow > net Income

-9530000

Quarters > 3 > cash Flow > depreciation

146000

Quarters > 3 > cash Flow > change In Working Capital

-2550000

Quarters > 3 > cash Flow > cash From Operations

-10942000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

8730000

Quarters > 3 > cash Flow > cash From Financing

-13000

Quarters > 3 > cash Flow > net Change In Cash

-2225000

Quarters > 3 > ratios > PE

-0.7824634906476318

Quarters > 3 > ratios > PB

0.8294785814587019

Quarters > 3 > ratios > ROE

-6.691100064594041

Quarters > 3 > ratios > ROA

-6.113716408239724

Quarters > 3 > ratios > FCF

-10942000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-15.556402265644548

Quarters > 3 > health Score

33

Valuation > metrics > PE

-1.8965982622668274

Valuation > metrics > PB

1.2955472299695052

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-25.33126417571923

Profitability > metrics > ROA

-21.69915683595021

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.1884705958956884

Risk > final Score

80

Risk > verdict

Low

Liquidity > metrics > Current Ratio

24.000669344042837

Liquidity > metrics > Quick Ratio

24.000669344042837

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-706

Prev Risks > 1

11

Prev Risks > 2

-16

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:21:44.612Z